Latest Elwood V. Jensen Stories
Researchers from Baylor College of Medicine have been awarded more than $5 million from Susan G. Komen for the Cure for three new breast cancer research grants, including a prestigious Komen Promise Grant.
Medical researchers at the University of Leeds have come a step closer to understanding how to stop breast cancers from coming back.
University of Houston (UH) researchers have their sights set on developing possible treatments for breast and colon cancer.
Patterns of radiation usage in breast conserving therapy for women 70 years and older with stage I breast cancer are changing: more women are opting for radioactive implants and those with estrogen positive tumors are opting out of radiation therapy.
For women with hormone receptor-positive breast cancers, treatment after initial surgery is straightforward: a daily dose of an anti-hormone drug will block the tumor from fuel needed for growth, and keep the breast cancer at bay.
Researchers from the Kimmel Cancer Center at Jefferson have identified a protein relationship that may be an ideal treatment target for ER+ breast cancer. The study was reported in the July 15 issue of Cancer Research.
Agendia, a molecular cancer diagnostics company, has launched TargetPrint, a new diagnostic test that allows physicians to quantitatively determine the gene expression levels of the estrogen receptor, progesterone receptor and human epidermal growth factor receptor 2 in breast cancer tumor biopsies.
CHICAGO (Reuters) - Advances in chemotherapy are proving a life-saving boon for women whose breast cancer has spread to the lymph nodes but who have tumors that are not fueled by estrogen, a study said on Tuesday.
- a slit in a tire to drain away surface water and improve traction.